Correction of the NSE concentration in hemolyzed serum samples improves its diagnostic accuracy in small-cell lung cancer

Neuron-specific enolase (NSE) is a well-known biomarker for the diagnosis, prognosis and treatment monitoring of small-cell lung cancer (SCLC). Nevertheless, its clinical applicability is limited since serum NSE levels are influenced by hemolysis, leading to falsely elevated results. Therefore, this...

Descripción completa

Detalles Bibliográficos
Autores principales: Genet, Sylvia A.A.M., Visser, Esther, van den Borne, Ben E.E.M., Soud, Maggy Youssef-El, Belderbos, Huub N.A., Stege, Gerben, de Saegher, Marleen E.A., Eduati, Federica, Broeren, Maarten A.C., van Dongen, Joost, Brunsveld, Luc, van de Kerkhof, Daan, Scharnhorst, Volkher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343637/
https://www.ncbi.nlm.nih.gov/pubmed/32676167
http://dx.doi.org/10.18632/oncotarget.27664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343637/
https://www.ncbi.nlm.nih.gov/pubmed/32676167
http://dx.doi.org/10.18632/oncotarget.27664

Ejemplares similares